Overview
Victoza 6 mg/ml Pen contains Liraglutide, a GLP-1 receptor agonist used in the treatment of type 2 diabetes mellitus. It helps lower blood sugar levels by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying. Victoza is administered as a once-daily subcutaneous injection and is also known to support weight reduction and improve cardiovascular outcomes in diabetic patients.





